$21.34
4.90% today
Nasdaq, Apr 04, 07:46 pm CET
ISIN
US09062W2044
Symbol
BLFS

BioLife Solutions, Inc. Target price 2025 - Analyst rating & recommendation

BioLife Solutions, Inc. Classifications & Recommendation:

Buy
100%

BioLife Solutions, Inc. Price Target

Target Price $31.33
Price $22.44
Potential
Number of Estimates 9
9 Analysts have issued a price target BioLife Solutions, Inc. 2026 . The average BioLife Solutions, Inc. target price is $31.33. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 9 Analysts recommend BioLife Solutions, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioLife Solutions, Inc. stock has an average upside potential 2026 of . Most analysts recommend the BioLife Solutions, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 82.25 97.03
8.42% 17.97%
EBITDA Margin -1.99% 22.13%
91.82% 1,209.87%
Net Margin -44.49% -5.73%
53.88% 87.12%

9 Analysts have issued a sales forecast BioLife Solutions, Inc. 2025 . The average BioLife Solutions, Inc. sales estimate is

$97.0m
Unlock
. This is
14.39% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$98.0m 13.53%
Unlock
, the lowest is
$95.5m 15.74%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $82.3m 8.42%
2025
$97.0m 17.97%
Unlock
2026
$116m 19.29%
Unlock
2027
$142m 22.79%
Unlock
2028
$172m 20.95%
Unlock
2029
$206m 19.97%
Unlock

4 Analysts have issued an BioLife Solutions, Inc. EBITDA forecast 2025. The average BioLife Solutions, Inc. EBITDA estimate is

$21.5m
Unlock
. This is
363.79% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$24.0m 394.84%
Unlock
, the lowest is
$15.9m 295.21%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-1.6m 91.14%
2025
$21.5m 1,409.30%
Unlock
2026
$35.1m 63.46%
Unlock

EBITDA Margin

2024 -1.99% 91.82%
2025
22.13% 1,209.87%
Unlock
2026
30.32% 37.01%
Unlock

7 BioLife Solutions, Inc. Analysts have issued a net profit forecast 2025. The average BioLife Solutions, Inc. net profit estimate is

$-5.6m
Unlock
. This is
54.41% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-940k 92.29%
Unlock
, the lowest is
$-10.8m 11.53%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-36.6m 50.00%
2025
$-5.6m 84.80%
Unlock
2026
$5.4m 196.94%
Unlock
2027
$24.4m 352.50%
Unlock
2028
$46.0m 88.48%
Unlock
2029
$67.6m 46.94%
Unlock

Net Margin

2024 -44.49% 53.88%
2025
-5.73% 87.12%
Unlock
2026
4.66% 181.33%
Unlock
2027
17.16% 268.24%
Unlock
2028
26.74% 55.83%
Unlock
2029
32.76% 22.51%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.78 -0.12
50.00% 84.62%
P/E negative
EV/Sales 10.10

7 Analysts have issued a BioLife Solutions, Inc. forecast for earnings per share. The average BioLife Solutions, Inc. EPS is

$-0.12
Unlock
. This is
53.85% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.02 92.31%
Unlock
, the lowest is
$-0.23 11.54%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.78 50.00%
2025
$-0.12 84.62%
Unlock
2026
$0.12 200.00%
Unlock
2027
$0.52 333.33%
Unlock
2028
$0.98 88.46%
Unlock
2029
$1.44 46.94%
Unlock

P/E ratio

Current -86.47 608.77%
2025
-189.25 118.86%
Unlock
2026
195.13 203.11%
Unlock
2027
43.15 77.89%
Unlock
2028
22.90 46.93%
Unlock
2029
15.58 31.97%
Unlock

Based on analysts' sales estimates for 2025, the BioLife Solutions, Inc. stock is valued at an EV/Sales of

10.10
Unlock
and an P/S ratio of
10.87
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.65 49.14%
2025
10.10 16.80%
Unlock
2026
8.47 16.17%
Unlock
2027
6.90 18.56%
Unlock
2028
5.70 17.32%
Unlock
2029
4.75 16.64%
Unlock

P/S ratio

Current 9.31 58.65%
2025
10.87 16.81%
Unlock
2026
9.11 16.17%
Unlock
2027
7.42 18.56%
Unlock
2028
6.14 17.32%
Unlock
2029
5.11 16.64%
Unlock

Current BioLife Solutions, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Mar 06 2025
Northland Capital Markets
Locked
Locked
Locked Jan 08 2025
Benchmark
Locked
Locked
Locked Dec 19 2024
Keybanc
Locked
Locked
Locked Dec 13 2024
HC Wainwright & Co.
Locked
Locked
Locked Nov 18 2024
Craig-Hallum
Locked
Locked
Locked Nov 13 2024
TD Cowen
Locked
Locked
Locked Nov 13 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 06 2025
Locked
Northland Capital Markets:
Locked
Locked
Jan 08 2025
Locked
Benchmark:
Locked
Locked
Dec 19 2024
Locked
Keybanc:
Locked
Locked
Dec 13 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 18 2024
Locked
Craig-Hallum:
Locked
Locked
Nov 13 2024
Locked
TD Cowen:
Locked
Locked
Nov 13 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today